MicroRNA-208a increases myocardial endoglin expression and myocardial fibrosis in acute myocardial infarction

Canadian Journal of Cardiology

Volumn 31, Issue 5, 2015, Pages 679-690

  Shyu, Kou Gi ^a,b   Wang, Bao Wei ^a   Cheng, Wen Pin ^a   Lo, Huey Ming ^a,c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; ENDOGLIN; MICRORNA; MICRORNA 208A; MYOSIN HEAVY CHAIN BETA; UNCLASSIFIED DRUG; VALSARTAN; ENDOGLIN PROTEIN, RAT; HEPTANOIC ACID DERIVATIVE; MIRN208 MICRORNA, RAT; PYRROLE DERIVATIVE; SIGNAL PEPTIDE; TETRAZOLE DERIVATIVE; VALINE;

ACUTE HEART INFARCTION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART SIZE; HEMODYNAMICS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE CELL; MYOCARDIAL INFARCTION; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION REGULATION; HEMODYNAMICS; HEPTANOIC ACIDS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICRORNAS; MUSCLE CELLS; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; PYRROLES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; TETRAZOLES; VALINE; VENTRICULAR REMODELING;

EID: 84928791848     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.12.026     Document Type: Article

References (39)

1. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Phys Rev 1999, 79:215-262.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Place R.F., Li L.C., Pookot D., Noonan E.J., Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 2008, 105:1608-1613.
4. Ikeda S., Kong S.W., Lu J., et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007, 31:367-373.
5. Sayed D., Hong C., Chen I.Y., Lypowy J., Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007, 100:416-424.
6. Biasucci L.M., Cardillo M.T. MicroRNA and myocardial infarction: a mystery turning into glory?. JAm Coll Cardiol 2013, 62:999-1001.
7. Shi B., Guo Y., Wang J., Gao W. Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction. BMC Cardiovasc Disord 2010, 10:11.
8. van Rooji E., Sutherland L.B., Thatcher J.E., et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008, 105:13027-13032.
9. Port J.D., Walker L.A., Polk J., et al. Temporal expression of MiRs in a mouse model of myocardial infarction. Phys Genomics 2011, 43:1087-1095.
10. Liebetrau C., Mollmann H., Dörr O., et al. Release of circulating muscle-enriched microRNAs inn patients undergoing transcoronary ablation of septal hypertrophy. JAm Coll Cardiol 2013, 62:992-998.
11. D'Alessandra Y., Devanna P., Limana F., et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010, 31:2765-2773.
12. van Rooij E., Sutherland L.B., Qi X., et al. Control of stress dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
13. Callis T.E., Pandya K., Seok H.Y., et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. JClin Invest 2009, 119:2772-2786.
14. Wang B.W., Wu G.J., Cheng W.P., Shyu K.G. MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart. PLoS On 2014, 9:e84188.
15. Shyu K.G., Wang B.W., Wu G.J., Lin C.M., Chang H. Mechanical stretch via transforming growth factor-β1 activates microRNA208a to regulate endoglin expression in cultured rat cardiac myoblasts. Eur J Heart Fail 2013, 15:36-45.
16. Wang B.W., Wu G.J., Cheng W.P., Shyu K.G. Mechanical stretch via transforming growth factor-β1 activates microRNA-208a to regulate hypertrophy in cultured rat cardiac myocytes. JFormos Med Assoc 2013, 112:635-643.
17. Fonsatti E., Altomonte M., Arslan P., Maio M. Endoglin (CD105): a target for anti-angiogenic cancer therapy. Curr Drug Targets 2003, 4:291-296.
18. Chen K., Mehta J.L., Li D., Joseph L., Joseph J. Transforming growth factor-β receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res 2004, 95:1167-1173.
19. Rodríguez-Barbero A., Obreo J., Alvarez-Munoz P., et al. Endoglin modulation of TGF-β1-induced collagen synthesis is dependent on ERK1/2 MAPK activation. Cell Physiol Biochem 2006, 18:135-142.
20. Shyu K.G., Wang M.T., Wang B.W., et al. Intramyocardial injection of naked DNA encoding HIF-1α/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc Res 2002, 54:576-583.
21. Shyu K.G., Lu M.J., Chang H., et al. Carvedilol modulates the expression of hypoxia-inducible factor-1α and vascular endothelial growth factor in a rat model of volume-overload heart failure. JCard Fail 2005, 11:152-159.
22. Kapur N.K., Heffernan K.S., Yunis A.A., et al. Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure. Am J Cardiol 2010, 106:1770-1776.
23. Yanavitski M., Givertz M.M. Novel biomarkers in acute heart failure. Curr Heart Fail Rep 2011, 8:206-211.
24. Benjamin I.J. Targeting endoglin, an auxiliary transforming growth factor-β coreceptor, to prevent fibrosis and heart failure. Circulation 2012, 125:2689-2691.
25. Li L.C., Okino S.T., Zhao H., et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 2006, 103:17337-17342.
26. Ma F., Liu X., Wang P., et al. MicroRNA-4661 upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. JImmunol 2010, 184:5053-5059.
27. Portnoy V., Huang V., Place R.F., Li L.C. Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA 2011, 2:748-760.
28. Huang V., Place R.F., Portnoy V., et al. Upregulation of cyclin B1 by miRNA and its implication in cancer. Nucleic Acids Res 2012, 40:1695-1707.
29. Fiedler J., Thum T. MicroRNAs in myocardial infarction. Arterioscler Thromb Vasc Biol 2013, 33:201-205.
30. Xiao J., Shen B., Li J., et al. Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction. Int J Clin Exp Med 2014, 7:136-141.
31. De Rosa S., Fichtlscherer S., Lehmann R., et al. Transcoronary concentration gradients of circulating microRNAs. Circulation 2011, 124:1936-1944.
32. Wang G.K., Zhu J.Q., Zhang J.T., et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010, 31:659-666.
33. Ji X., Takahashi R., Hiura Y., et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009, 55:1944-1949.
34. Horwich T.B., MacLellan R., Fonarow G.C. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. JAm Coll Cardiol 2004, 43:642-648.
35. Khush K.K., Waters D.D., Bittner V., et al. Effect of high-dose atorvastatin on hospitalization for heart failure: subgroup analysis of the treating to new targets (TNT) study. Circulation 2007, 115:576-583.
36. Pospisilova N., Semeeky V., Jamborova G., et al. Endoglin expression in hypercholesterolemia and after atorvastatin treatment in apo-E deficient mice. JPharm Pharm Sci 2006, 9:388-397.
37. Nachtigal P., Pospisilova N., Jamborova G., et al. Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment. Can J Physiol Pharmacol 2007, 85:767-773.
38. Chen J., Mehta J. Angiotensin II-mediated oxidative stress and procollagen-I expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone. Am J Physiol Heart Circ Physiol 2006, 291:H1738-H1745.
39. Brown J.H., Del Re D.P., Sussman M.A. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ Res 2006, 98:730-742.